SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as crude prices climb amid reported Middle East shipping and energy-infrastructure attacks, fueling concerns about supply disruptions. Traders are divided between expecting the supply-risk rally to continue and anticipating a pullback if tensions ease; some also caution that the expiring WTI contract can distort comparisons with the next contract.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves sharp selloff is being tied to HSBCs bearish outlook, which flagged debt costs, financing needs and the risk that AI-compute demand may slow. Traders are split: bears see leverage as a threat to the neocloud business model, while bulls cite AI demand and the companys backlog; Goldmans upgrade and ARK buying have not resolved the concerns.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A tech-led rebound after the recent selloff, ahead of major megacap earnings, is driving QQQ discussion. Traders are divided over whether it marks a durable recovery or a relief rally that could fade, with AI investment and debt concerns and surging oil prices adding to caution.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras shares have slid to post-IPO lows amid concern over insider selling and successive lockup share releases, with traders also pointing to a TD Cowen price-target cut and questions about growth, scaling, and reliance on OpenAI. The discussion is sharply divided between calls for more downside and buyers arguing the selloff is overdone and the AI-chip technology has long-term potential.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale shares are under pressure after UBS downgraded the stock, citing long commercialization timelines and limited firm customer commitments, with uncertainty around the proposed TVA deployment adding to execution concerns. Traders are split between viewing the selloff as an overreaction and seeing it as confirmation of risks facing NuScale and the broader nuclear sector.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospaces third-quarter earnings beat and raised 2026 guidance are driving attention, with traders also citing stronger orders. Many view the report as bullish, while others are cautious about whether the stock can hold its post-earnings strength amid muted or weakening price action.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is drawing attention after reporting a better-than-expected third quarter and raising its automotive free-cash-flow outlook while narrowing full-year guidance, prompting a broadly positive earnings reaction. Some traders remain cautious about cost pressures and scrutiny of the 6.2L engine recall remedy.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

Hot inflation readings and elevated yields have intensified concerns about Fed tightening, weighing on rate-sensitive small caps and keeping IWM near key support after a sharp pullback. Traders are split between expecting further downside and looking for an oversold bounce as yields ease and money rotates toward smaller companies.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

A sharp selloff in AI infrastructure and neocloud stocks, fueled by concerns about whether massive buildout spending can earn adequate returns and by CoreWeaves debt risks, has dominated discussion around Nebius. Traders are divided over whether the pullback and subsequent bounce are an opportunity, with some arguing Nebius is better positioned than peers and others worried that sector-wide financing concerns will keep pressuring shares.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grummans Q3 results and higher full-year guidance are drawing attention, with traders also citing a record backlog and stronger B-21 and Sentinel activity. Despite the upbeat report, shares remain under pressure as investors weigh margin and cash-flow concerns against the improved outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vaso Stock Surges 149% in a Year: What's Behind the Rally?

VASO is gaining from higher equipment deliveries, growing deferred commissions and a sharper healthcare focus, though partner dependence and margin pressures persist.

Research conducted at University of Michigan published in Anesthesia & Analgesia Practice demonstrates GE HealthCare End-tidal Control software may help to reduce fresh gas flow

GE HealthCare (Nasdaq: GEHC) today announced the publication of research conducted at the University of Michiganiv evaluating the use of End-tidal Control software across a large multisite academic health system in Anesthesia & Analgesia Practice. The retrospective observational study analyzed...

ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum?

Intuitive Surgical's Q3 earnings hinge on robotic surgery growth, system demand and margins amid slowing US procedures, China headwinds and premium valuation.

GE HealthCare's MINItrace Magni achieves CE Mark; Copper-64 expands PETtrace Solid Target Platform beyond Gallium-68

GE HealthCare (Nasdaq: GEHC) today announced that its MINItrace Magni cyclotron has achieved CE Mark and that its PETtrace Solid Target Platform is expanding beyond Gallium-68 with support for Copper-64 (Cu) production. Together, the developments reflect the companys focus on helping institutions...

Stocktwits Biotech Dealmaker — Viatris And GE Healthcare Buy What They Can Sell; Biohaven And Alector Sell Rights

Equity

Drugmakers this week did not purchase experimental drug candidates but invested in approved drugs and a factory that makes imaging agents. 


GE HealthCare to announce third quarter 2026 results on October 28, 2026

GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2026 financial results before the market opens on Wednesday, October 28, 2026. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will...

GE HealthCare Expands U.S. PET Radiopharma Reach With SOFIE Deal

GEHC's $945M SOFIE Biosciences deal will expand its U.S. PET radiopharmaceutical footprint and boost exposure to precision care growth.

GE HealthCare To Acquire SOFIE Biosciences For $945M — Here’s What GEHC Investors Need To Know

GE HealthCare is adding SOFIE’s PET radiopharmaceutical manufacturing footprint and U.S. rights to FAPI-74 as it expands its presence in precision diagnostics.


Here's How Tempus AI is Capitalizing on AI-ECG Market Growth

TEM is expanding its cardiovascular portfolio with FDA-cleared AI-ECG tools targeting complex cardiac conditions.

GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.

GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027...

GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment provides scanning devices, clinical applications, service capabilities, and digital solutions. The AVS segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The PCS segment specializes in providing medical devices, consumables, services, and digital solutions. The PDx segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded in 1892. It was incorporated on May 16, 2022 and is headquartered in Chicago, IL.

GE HealthCare Technologies Inc

Bearish Sentiment

<ul class="summary-bullets"><li><a class="mention" data-mention="$VTRS" data-symbol-id="VTRS" href="https://stocktwits.com/symbol/VTRS" target="_blank">Viatris</a> agreed on Thursday to buy Pacira BioSciences for $1.65 billion in cash, or $36.50 a share.</li><li>GE HealthCare agreed to pay $945 million in cash for Sofie Biosciences, a private U.S. firm that makes radioactive tracers for PET scans.</li><li>Biohaven licensed Asian rights to its antibody-clearing drugs to Japan’s Ono Pharmaceutical; Alector signed a separate license with Genentech.</li></ul><p>U.S.-listed drugmakers spent the week selling rights or buying products they can already sell. Cash went to approved pain drugs, a factory that makes imaging agents, and two license deals, including one that leaves the American company in charge of its home market.</p><p>The companies did not purchase experimental drug candidates as they did last week when drugmakers, including Novo Nordisk and Novartis, invested in experimental drugs.</p><h2 class="st-heading-2">Viatris Buys A Pain Franchise</h2><p>Viatris (VTRS) agreed on Thursday to buy Pacira BioSciences (PCRX) for $1.65 billion in cash, or $36.50 a share. That was a premium of about 45% to Pacira’s last close.</p><p>Pacira sells Exparel, a long-acting numbing shot used after surgery, and Zilretta, an injection for knee arthritis. Pacira expects Exparel sales of $600 million to $620 million this year. Viatris, which is waiting on a U.S. decision for its own non-opioid pain drug, said the products fit its push into branded medicines and that it would try to sell them in more countries. The deal is expected to close by the end of 2026. Pacira shares closed Thursday at $36.39, up 44%.</p><h2 class="st-heading-2">GE Healthcare Buys The Delivery Network</h2><p>GE HealthCare (GEHC) agreed to pay $945 million in cash for Sofie Biosciences, a private U.S. firm that makes radioactive tracers for PET scans. Sofie runs 15 manufacturing sites and 21 cyclotrons. The tracers fade within hours, so the plant has to be near the hospital. GE also gets U.S. rights to FAPI-74, an experimental cancer-imaging agent it already controls outside the country. Sofie already makes GE’s heart-scan product Flyrcado. Closing is expected in the first half of 2027.</p><h2 class="st-heading-2">Two Biotechs License Out</h2><p>Biohaven (BHVN) licensed Asian rights to its antibody-clearing drugs to Japan’s Ono Pharmaceutical. The package is $80 million at signing and a further $20 million expected within about a year, plus royalties of roughly 20 percent on Ono’s sales in Japan and other Asian markets. Biohaven keeps the United States, Europe, and China. The lead drug, BHV-1300, is in a late-stage study for Graves’ disease.</p><p>Alector (ALEC) signed a separate license with Genentech, the U.S. unit of Roche (RHHBY). Alector gets $100 million upfront and could receive up to $1.17 billion more for AL-050, an experimental enzyme therapy aimed at Parkinson’s and other brain disorders. Genentech gained worldwide rights to develop the AL-050 program. The deal lands three months after GSK (GSK) walked away from an older Alector partnership.</p><h2 class="st-heading-2">How Did Retail Traders React?</h2><p>On Stocktwits, retail sentiment around VTRS and PCRX &nbsp;was in 'bullish' territory over the past 24 hours, while GEHC and BHVN stayed within the 'neutral' territory. Sentiment around ALEC stayed within the 'extremely bullish' territory.</p><p>While VTRS has gained 42% year-to-date, PCRX has added 40%, BHVN 7%, and ALEC 33%. Meanwhile, GEHC has fallen 20%.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/mrna-stock-sets-new-52-week-high-as-nasdaq-100-reentry-meets-nih-cancer-vaccine-push/cZxGGuoRBnj">MRNA Stock Sets New 52-Week High As Nasdaq-100 Reentry Meets NIH Cancer-Vaccine Push</a></p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com</p>

Assortment of multi-colored pills, tablets, and capsules scattering on a vibrant blue surface representing healthcare and medicine. Source: Getty Images

Drugmakers this week did not purchase experimental drug candidates but invested in approved drugs and a factory that makes imaging agents. 

Alector Inc

Biohaven Pharmaceutical Holding Company Ltd

Pacira BioSciences Inc

Viatris Inc

Track GEHC stock price, charts, news and real-time market activity on Stocktwits. Join the GEHC message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around GE HealthCare Technologies Inc stock.

GEHC Stock Price Today - GE HealthCare News, Charts, Retail Sentiment

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Feed

News

Sentiment

Earnings

Fundamentals

Info

GEHC News